生物标志物 生物标志物
Alena Marie Smith1, Sara A Lorkiewicz1, Laia Montoliu-Gaya2
1Stanford University School of Medicine, Stanford, CA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
血生物标志物,包括pTau217,在患有α-synucleinopathy (αSyn) 的个体中准确地检测出β-粉样蛋白 (Aβ) 病理. 这一发现支持它们在有关神经退行性疾病的临床试验中使用.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 神经退行性疾病 神经退行性疾病
背景情况:
- 同时存在的神经病理,如氨基粉症 (Aβ),病和α-synucleinopathy (αSyn) 复杂的神经退行性疾病的诊断和治疗.
- 了解多种病理存在时的血生物标志物的表现,对于准确的诊断和个性化医学至关重要.
研究的目的:
- 调查血生物标志物的诊断准确性,以检测有或没有αSyn病理的个体的Aβ病理.
- 评估血生物标志物的实用性,以区分神经退行性疾病亚型.
主要方法:
- 在180名参与者中分析了5种血生物标志物 (pTau181,pTau217,Aβ42/40,GFAP,NfL).
- 通过使用CSFSAAmplify-αSYN测试和Aβ42/40比率来确定αSyn和Aβ状态.
- 利用ROC曲线分析来评估预测Aβ状态的诊断准确性,比较αSyn+和αSyn-组之间的结果.
主要成果:
- 血pTau181,pTau217,Aβ42/40和GFAP在Aβ+组中升高,不论αSyn状态如何.
- 血pTau217在αSyn+个体中检测Aβ的准确度最高 (AUC高达0.92).
- 当包括年龄,性别和APOE4状态时,αSyn-参与者的Aβ检测血NfL准确性得到改善.
结论:
- 血pTau217是一种可靠的生物标志物,用于检测αSyn病理的个体中的Aβ.
- 这些发现表明,血pTau217可以帮助对针对α-synucleinopathies的临床试验进行患者查和分层.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516